Thomas Witzig, M.D

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

• Primary effusion lymphoma→
• Interdigitating dendritic cell sarcoma→
• Enteropathy-associated T-cell lymphoma→
• MALT lymphoma→
• Subcutaneous panniculitis-like T-cell lymphoma→
• Blastic plasmacytoid dendritic cell neoplasm→
• Diffuse large B-cell lymphoma of the central nervous system→
• Primary cutaneous peripheral T-cell lymphoma not otherwise specified→
• Waldenström Macroglobulinemia→
• NK-cell enteropathy→

Clinical trials (5)

• NCT02652715
• NCT00088881
• NCT00012298
• NCT01719250
• NCT00438880

Verify independently

• ClinicalTrials.gov PI search for Thomas Witzig
• NPPES NPI registry entry

Other specialists for Primary effusion lymphoma

Peers ranked by clinical-trial PI role, publications, and verification quality.

• Richard F. Little, MD
  NCI - HIV and AIDS Malignancy Branch
• Robert Yarchoan, M.D.
  National Cancer Institute (NCI)
  Maryland
• Ramya M Ramaswami, M.D.
  National Cancer Institute (NCI)
  Maryland
• Pei Wang, PhD
  Eureka Therapeutics Inc.
• Wyndham H Wilson, M.D., MD, PhD
  National Cancer Institute (NCI)
  MD
• Stephen M Ansell, M.D
  Dana-Farber - Harvard Cancer Center LAO
  MN
• Frank G Basile, M.D., MD
  Schrodinger Inc.
  RI
• Ramya Ramaswami, M.D., MD MPH
  National Cancer Institute (NCI)
  MD

See all specialists for Primary effusion lymphoma →